Ethyl Bromo Acetate

Ethyl Bromo Acetate

SCHEMBL4433807

CCCCOC(=O)CBr.CCOC(=O)CBr

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.71
TRPA1 O75762 1/20 0.71
FAAH O00519 2/20 0.55
NAAA Q02083 1/20 0.50
CYP2C19 P33261 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.48
ATM Q13315 1/20 0.47
DGKA P23743 1/20 0.45
MGAM O43451 1/20 0.44
GAA P10253 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
TSHR P16473 2/20 0.44
HPGD P15428 1/20 0.44
RAD52 P43351 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HCAR2 Q8TDS4 1/20 0.41
CYP1A2 P05177 1/20 0.41
HTR2C P28335 1/20 0.41
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL362068 0.94
SCHEMBL10472630 0.87 FAAH (0.69) ALDH1A1TRPA1FAAHNAAACYP2C19
SCHEMBL1037246 0.85 FAAH (0.72) ALDH1A1TRPA1FAAHNAAACYP2C19
SCHEMBL7934446 0.85 FAAH (0.72) ALDH1A1TRPA1FAAHNAAACYP2C19
SCHEMBL1037235 0.85 FAAH (0.72) ALDH1A1TRPA1FAAHNAAACYP2C19
SCHEMBL4283094 0.85 FAAH (0.72) ALDH1A1TRPA1FAAHNAAACYP2C19
SCHEMBL7453244 0.85 FAAH (0.72) ALDH1A1TRPA1FAAHNAAACYP2C19
SCHEMBL2431478 0.85 FAAH (0.72) ALDH1A1TRPA1FAAHNAAACYP2C19
SCHEMBL6783832 0.85 FAAH (0.72) ALDH1A1TRPA1FAAHNAAACYP2C19
SCHEMBL28679834 0.85 FAAH (0.72) ALDH1A1TRPA1FAAHNAAACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121600-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2009-11-25 EP disclosed
WO-2008099000-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-08-21 WO disclosed